Trivalent ultrashort lipopeptides are potent pH dependent antifungal agents

Journal of Medicinal Chemistry
Christopher J ArnuschYechiel Shai

Abstract

The activity of antimicrobial peptides (AMPs) that contain a large proportion of histidine residues (pK(a) ∼ 6) depends on the physiological pH environment. Advantages of these AMPs include high activity in slightly acidic areas of the human body and relatively low toxicity in other areas. Also, many AMPs are highly active in a multivalent form, but this often increases toxicity. Here we designed pH dependent amphiphilic compounds consisting of multiple ultrashort histidine lipopeptides on a triazacyclophane scaffold, which showed high activity toward Aspergillus fumigatus and Cryptococcus neoformans at acidic pH, yet remained nontoxic. In vivo, treatment with a myristic acid conjugated trivalent histidine-histidine dipeptide resulted in 55% survival of mice (n = 9) in an otherwise lethal murine lung Aspergillus infection model. Fungal burden was assessed and showed completely sterile lungs in 80% of the mice (n = 5). At pH 5.5 and 7.5, differing peptide-membrane interactions and peptide nanostructures were observed. This study underscores the potential of unique AMPs to become the next generation of clinical antimicrobial therapy.

References

Mar 1, 1984·The American Journal of Medicine·J W Gold
Mar 11, 2000·American Journal of Respiratory and Critical Care Medicine·J F HuntB Gaston
Jun 20, 2001·Bioorganic & Medicinal Chemistry Letters·M C MonneeRob M J Liskamp
Jan 25, 2002·Nature·Michael Zasloff
Feb 11, 2005·Nature Reviews. Microbiology·Kim A Brogden
Jul 13, 2005·Biochemistry·Arik Makovitzki, Yechiel Shai
May 18, 2006·The FEBS Journal·Victoria RydengårdArtur Schmidtchen
Oct 14, 2006·Proceedings of the National Academy of Sciences of the United States of America·Arik MakovitzkiYechiel Shai
Dec 13, 2006·Antimicrobial Agents and Chemotherapy·Yuxin ChenRobert S Hodges
Jan 27, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·A James MasonAntoine Kichler
Apr 11, 2007·Antimicrobial Agents and Chemotherapy·Anton Y PelegDavid L Paterson
Aug 7, 2007·Biochemical and Biophysical Research Communications·Zhigang TuJun F Liang
Sep 22, 2007·Chembiochem : a European Journal of Chemical Biology·Dirk-Jan van ZoelenRob M J Liskamp
Oct 20, 2007·Biochemistry·Christopher J ArnuschRoland J Pieters
Jan 15, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility T
Mar 26, 2008·Chemical Communications : Chem Comm·H Bauke AlbadaRob M J Liskamp
Jul 25, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Menno J OudhoffEnno C I Veerman
Sep 25, 2008·Journal of Combinatorial Chemistry·H Bauke Albada, Rob M J Liskamp
Nov 8, 2008·Biochemistry·Christopher J ArnuschEefjan Breukink
Apr 24, 2009·Solid State Nuclear Magnetic Resonance·Ayyalusamy Ramamoorthy
Jul 16, 2009·Protein and Peptide Letters·Roland J PietersEefjan Breukink
Aug 5, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Menno J OudhoffEnno C I Veerman
Apr 16, 2010·Pharmaceutical Research·Bérangère Langlet-BertinAntoine Kichler
Oct 20, 2010·Antimicrobial Agents and Chemotherapy·Nathaniel P ChongsiriwatanaAnnelise E Barron
Jan 20, 2011·Antimicrobial Agents and Chemotherapy·Laurent PoirelPatrice Nordmann
Aug 3, 2011·Pharmacognosy Research·A B D Selvam
Oct 19, 2011·Antimicrobial Agents and Chemotherapy·Christopher J ArnuschYechiel Shai

Citations

Feb 6, 2014·PloS One·Rajamani LakshminarayananRoger W Beuerman
Dec 5, 2012·Beilstein Journal of Organic Chemistry·H Bauke AlbadaNils Metzler-Nolte
Aug 29, 2012·Expert Opinion on Drug Delivery·Abhinay SharmaAtul Kumar Johri
Jun 7, 2013·Medicinal Research Reviews·Ling ZhangCheng-He Zhou
Jun 10, 2014·Journal of Peptide Science : an Official Publication of the European Peptide Society·Patricia Kemayo KoumkouaBurkhard Bechinger
Dec 20, 2014·Journal of Peptide Science : an Official Publication of the European Peptide Society·Burkhard Bechinger
Nov 23, 2016·Journal of Dental Research·Burkhard Bechinger, S-U Gorr
Apr 14, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Lisa LombardiArianna Tavanti
Aug 24, 2017·ChemMedChem·Sushil N BenkeHosahudya N Gopi

Related Concepts

Antibiotics
Antibiotics, Antifungal
Aspergillus fumigatus
Candida albicans
Cryptococcus neoformans var. grubii
Gram-Negative Bacteria
Gram-Positive Bacteria
Hemolysis
Hydrogen-Ion Concentration
Lung

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.